Galetskiĭ S A, Kopyl'tsov V N, Zhordaniia K I, Solov'ev Iu N, Revazova E S
Biull Eksp Biol Med. 1990 Aug;110(8):186-9.
Three new human cervical carcinoma xenografts was established from clinical tumor specimens of patients with I-II stages of disease. Growth characteristics of models are writing. Xenografts designated CC 9, 24 and 25 contain integrated DNA HPV, complemented DNA HPV-16. DNA CC 5 contain neither DNA HPV-16, nor DNA HPV-18.
从I-II期疾病患者的临床肿瘤标本中建立了三种新的人宫颈癌异种移植模型。正在撰写模型的生长特征。命名为CC 9、24和25的异种移植模型含有整合型DNA人乳头瘤病毒(HPV)、互补DNA HPV-16。DNA CC 5既不含DNA HPV-16,也不含DNA HPV-18。